Updated: January 25, 2026
What Is Loteprednol Etabonate? Uses, Dosage, and What You Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Loteprednol Etabonate (Lotemax, Alrex) is a steroid eye drop used after eye surgery, for allergies, and to treat eye inflammation. Here's everything you need to know in 2026.
Loteprednol Etabonate is a prescription steroid eye drop used to treat inflammation in the eye. You might know it better by its brand names: Lotemax, Alrex, Eysuvis, or Inveltys. It's one of the most widely prescribed ophthalmic corticosteroids in the United States, particularly after eye surgery and during allergy season.
What Is Loteprednol Etabonate?
Loteprednol Etabonate is a corticosteroid — a synthetic steroid — that was specifically designed for use in the eye. It belongs to a class of medications called ophthalmic steroids, or eye steroids. It was FDA-approved in 1998 and is manufactured primarily by Bausch + Lomb under the Lotemax brand.
What makes Loteprednol Etabonate different from older steroid eye drops is its "soft drug" design. It's engineered to break down rapidly into inactive compounds after it does its job in the eye. This means it has a lower risk of raising eye pressure (intraocular pressure) and essentially no systemic (whole-body) side effects at normal ophthalmic doses — your blood level of the drug is virtually undetectable after using the drops.
What Is Loteprednol Etabonate Used For?
Loteprednol Etabonate is FDA-approved for several specific conditions depending on the formulation:
Post-operative eye inflammation and pain: Used after cataract surgery and other eye procedures to reduce swelling, pain, and redness during healing. This is the most common use.
Seasonal allergic conjunctivitis: Alrex (0.2% suspension) is approved for temporary relief of seasonal eye allergy symptoms like itching and redness.
Dry eye disease: Eysuvis (0.25% suspension) is specifically approved for short-term treatment of the signs and symptoms of dry eye disease.
Other ocular inflammatory conditions: Doctors also use Loteprednol for uveitis, episcleritis, vernal keratoconjunctivitis, giant papillary conjunctivitis, and other inflammation of the eye surface and front of the eye.
Available Formulations and Brand Names
Loteprednol Etabonate is available in multiple formulations — this variety is part of why it can be confusing to patients:
Alrex 0.2% suspension — seasonal allergic conjunctivitis; generic available
Eysuvis 0.25% suspension — dry eye disease; no generic
Lotemax 0.5% suspension and gel — ocular inflammation; generic available
Lotemax SM 0.38% gel — post-surgical; no generic; submicron particle technology for improved penetration
Lotemax ointment 0.5% — post-surgical; applied as a ribbon rather than drops
Inveltys 1% suspension — post-surgical; highest concentration; twice-daily dosing; no generic
How to Use Loteprednol Etabonate Correctly
General instructions for eye drops (suspension and gel):
Wash your hands thoroughly before and after using the drops
Shake the suspension well before each use (for suspensions); for Lotemax gel, invert the closed bottle and shake once
Tilt your head back, gently pull down your lower eyelid to create a small pocket
Apply the prescribed number of drops into the pocket (usually 1–2 drops)
Close your eye and press lightly on the inner corner (nasolacrimal duct) for 1–2 minutes — this helps absorption and reduces systemic drainage
Do not let the dropper tip touch your eye, hands, or any surface — this prevents contamination
For the ointment: apply a small ribbon (about 1/2 inch) inside the lower eyelid pocket. Close the eye and let the ointment spread. Expect blurred vision for a few minutes — this is normal with ointment formulations.
Typical Dosing Schedules
Post-op (Lotemax 0.5%): 1–2 drops, 4 times daily, beginning the day after surgery for 2 weeks
Post-op (Lotemax SM 0.38%): 1 drop, 3 times daily, beginning day after surgery for 2 weeks
Post-op (Inveltys 1%): 1–2 drops, twice daily (BID), beginning day after surgery for 2 weeks
Allergic conjunctivitis (Alrex 0.2%): 1 drop, 4 times daily, during allergy season
Dry eye (Eysuvis 0.25%): 1 drop, 4 times daily, for up to 2 weeks
Important Safety Information
Do not use if you have an active eye infection (herpes simplex, viral, fungal, or bacterial that hasn't been properly diagnosed)
Remove soft contact lenses before use; wait 15 minutes before reinserting
If using for more than 10 days, your doctor should check your eye pressure
Not approved for use in children under 18 years old
For a full breakdown of side effects to watch for, see our guide on Loteprednol Etabonate side effects.
Frequently Asked Questions
Loteprednol Etabonate is used to treat eye inflammation. FDA-approved uses include post-operative inflammation after eye surgery (Lotemax), seasonal allergic conjunctivitis (Alrex), and dry eye disease (Eysuvis). Doctors also prescribe it off-label for uveitis, episcleritis, and other ocular inflammatory conditions.
Both Lotemax and Alrex contain Loteprednol Etabonate, but at different concentrations and for different purposes. Alrex is 0.2% and is specifically approved for seasonal allergic conjunctivitis. Lotemax is 0.5% and is approved for post-operative inflammation and other ocular inflammatory conditions. Use only the formulation and strength your doctor prescribed.
Dosing depends on the formulation. Standard Lotemax 0.5% is typically used 4 times daily (QID). Lotemax SM 0.38% is used 3 times daily (TID). Inveltys 1% is used twice daily (BID). Alrex 0.2% for allergy is 4 times daily. Eysuvis for dry eye is 4 times daily for up to 2 weeks. Always follow your doctor's specific instructions.
Loteprednol Etabonate is considered a moderate-potency ophthalmic corticosteroid. It is less potent than Difluprednate or Prednisolone Acetate 1%, but more potent than Fluorometholone. Its "soft steroid" design makes it safer from a side-effect standpoint — it has a lower risk of raising eye pressure than most alternatives while still effectively reducing inflammation.
Do not stop Loteprednol Etabonate early without asking your doctor. Post-surgical inflammation can flare up if steroid treatment is stopped prematurely, potentially leading to complications. For allergic conjunctivitis, symptoms may return if you stop too early. Your doctor may also recommend tapering the dose rather than stopping abruptly.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Loteprednol Etabonate also looked for:
More about Loteprednol Etabonate
32,757 have already found their meds with Medfinder.
Start your search today.





